Popular Articles
Cellulite Cream

FDA Takes Enforcement Action Against Cheese Manufacturer
The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, filed a complaint seeking injunctive relief against Peregrina Cheese, Inc., (Peregrina Cheese), Brooklyn, N.Y. and two of its officers: Javier Peregrina and Isabel Peregrina.
generic viagra online
First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
Biogen Idec (NASDAQ: BIIB) announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subjects AVONEX MS Prevention Study). Based on the CHAMPS study, AVONEX was granted approval for use in patients who experienced their first clinical MS episode with MRI findings. The CHAMPIONS ten-year follow up showed that patients treated immediately after their first episode had significantly less chance of experiencing a second attack versus those patients with delayed treatment. These results at ten years also indicate that 80 percent of patients taking AVONEX were below an expanded disability status scale (EDSS) score of three. These data were presented as a poster at the Annual American Academy of Neurology (AAN) meeting.
News of the day
Cobalis Corporation Is Awarded Two New International Patents In Canada And Mexico For Its Revolutionary Anti-Allergy Relief Product PreHistin(R)
Cobalis Corporation (OTC:CLSC) was recently awarded two additional International Patents in Canada and Mexico and has a patent pending application in Japan. PreHistin® is patented, safe for long-term daily use and available without a prescription. It is available in a cherry flavored, all natural, proprietary cyanocobalamin (vitamin B12) sub-lingual lozenge that is taken twice daily to regulate allergy sufferers" response to both indoor and outdoor allergens with daily and year round usage.
Cardiovascular

International Groups Express Concern About Cambodian 'AIDS Colony'

In an open letter to Cambodia"s prime minister and health minister, more than 100 international HIV/AIDS advocates and human rights organizations "accused the Cambodian government of herding HIV-affected families into an "AIDS colony" outside the capital, Phnom Penh," the Guardian reports (McCurry, 7/28). According to CNN, the letter said the "de facto AIDS colony at Tuol Sambo ... is far away from the jobs, medical facilities and support services" residents had when they lived in the city. The human rights advocates said the HIV-positive residents were moved despite repeated appeals to the government, including from the U.N. (7/28). The groups said they are very concerned about the "life-threatening" conditions in the settlement where 40 families live in "sheet-metal sheds without running water or proper sanitation," writes the Guardian. According to the newspaper, the Cambodian government has spent the past two months moving HIV-positive people from the Borei Keila district of Phnom Penh to Tuol Sambo, "a flood-prone area 15 miles away" (7/28). In June, 20 families with HIV-positive members were evicted from their homes and moved to make way for a Ministry of Tourism garden, according to the Kaiser Daily Global Health Policy Report (6/19). Local officials acknowledged concerns about the settlement and said they were attempting to improve conditions, reports the Guardian. "We are trying to find clean water for them," said Mann Chhoeun, Phnom Penh"s deputy governor. Chhoeun added that there are plans to distribute free medicine via the Centre of Hope mission (7/28). The open letter "acknowledged the international recognition the Cambodian government has received for treating and supporting people living with HIV," CNN reports (7/28). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):